Generation Bio
Engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases.
Launch date
Employees
Market cap
$174m
Enterprise valuation
$51m (Public information from Sep 2024)
Share price
$2.59 GBIO
Cambridge Massachusetts (HQ)
Authorizing premium user...